Study into ancestry of Thomas Jefferson shows rare class of DNA

March 28, 2007

DNA testing carried out by University of Leicester geneticists and funded by The Wellcome Trust has thrown new light on the ancestry of one of the USA’s most revered figures, the third President, Thomas Jefferson.

Almost 10 years ago, the University of Leicester team, led by Professor Mark Jobling, together with international collaborators, showed that Thomas Jefferson had fathered at least one of the sons of Sally Hemings, a slave of Jefferson’s.

The work was done using the Y chromosome, a male-specific part of our DNA that passes down from father to son. Jefferson carried a very unusual Y chromosome type, which helped to strengthen the evidence in the historical paternity case.

Now, new techniques have been brought to bear on Jefferson’s Y chromosome, in a study reported in the American Journal of Physical Anthropology. The presidential chromosome turns out to belong to a rare class called ‘K2’, which is found at its highest frequency in the Middle East and Eastern Africa, including Oman, Somalia and Iraq. Its closest match was in a man from Egypt. Could this mean that the President had recent ancestry in the Middle East? A careful survey revealed a few K2 chromosomes in France, Spain and England. Together, the K2s form a diverse group that may, in fact, have been in western Europe for many thousands of years.

Further evidence for Jefferson’s British origins come from the finding that two out of 85 randomly recruited men named Jefferson share exactly the same Y chromosome as the President. Prof Jobling said: ‘The two men have ancestry in Yorkshire and the West Midlands, and knew of no historical connection to the USA. They were amazed and fascinated by the link, which connects them into Thomas Jefferson’s family tree, probably about 11 generations ago.’

The ultimate origins of K2 chromosomes remain a mystery, however, and need further investigation: while they may have been present in Europe since the Stone Age, another possibility is that K2s came to Europe with the Phoenicians, an ancient maritime trading culture that spread out across the Mediterranean from their home in what is now Lebanon. The US media has taken up a different theory, leading to the New York Times headline, ‘Jefferson – the first Jewish president?’: European K2 chromosomes may originate in Sephardic (Spanish) Jewish populations, who have their ultimate origins in the Middle East.

Prof Jobling said: ‘When we look closely at large collections of British Y chromosomes we find surprises, like this rare K2 lineage, and the African chromosome that we recently found in a Yorkshireman. These exotic chromosomes remind us of the complexity of British history and prehistory.’

Source: University of Leicester

Explore further: Drugs targeting chromosomal instability may fight a particular breast cancer subtype

Related Stories

Drugs targeting chromosomal instability may fight a particular breast cancer subtype

February 6, 2012
Another layer in breast cancer genetics has been peeled back. A team of researchers at Jefferson's Kimmel Cancer Center (KCC) led by Richard G. Pestell, M.D., PhD., FACP, Director of the KCC and Chair of the Department of ...

Conspicuous tRNA lookalikes riddle the human genome

October 8, 2014
Transfer RNAs (tRNAs) are ancient workhorse molecules and part of the cellular process that creates the proteins, critical building blocks of life that keep a cell running smoothly. A new discovery suggests that the number ...

Large multi-generational family helps unlock genetic secrets to developmental dysplasia of the hip

June 3, 2013
Research from Thomas Jefferson University is laying the foundation for a genetic test to accurately identify hip dysplasia in newborns so that early intervention can be initiated to promote normal development. This research ...

New biomarker to identify hepatitis B-infected patients at risk for liver cancer

April 3, 2012
Hepatitis B-infected patients with significantly longer telomeres — the caps on the end of chromosomes that protect our genetic data — were found to have an increased risk of getting liver cancer compared to those ...

Researchers seek to develop non-viral carrier for gene therapy use in bone repair

May 14, 2014
A team of researchers from the University of Delaware and Thomas Jefferson University has been awarded a $1.4-million grant from the National Institutes of Health to explore the use of non-viral gene therapy to enhance bone ...

Amplification of a Stat5 gene produces excess oncogenic protein that drives prostate cancer spread

May 7, 2013
An international group of investigators, led by researchers at Thomas Jefferson University's Kimmel Cancer Center, have solved the mystery of why a substantial percentage of castrate-resistant metastatic prostate cancer cells ...

Recommended for you

How rogue immune cells cross the blood-brain barrier to cause multiple sclerosis

November 21, 2017
Drug designers working on therapeutics against multiple sclerosis should focus on blocking two distinct ways rogue immune cells attack healthy neurons, according to a new study in the journal Cell Reports.

New simple test could help cystic fibrosis patients find best treatment

November 21, 2017
Several cutting-edge treatments have become available in recent years to correct the debilitating chronic lung congestion associated with cystic fibrosis. While the new drugs are life-changing for some patients, they do not ...

Researchers discover key signaling protein for muscle growth

November 20, 2017
Researchers at the University of Louisville have discovered the importance of a well-known protein, myeloid differentiation primary response gene 88 (MyD88), in the development and regeneration of muscles. Ashok Kumar, Ph.D., ...

New breast cell types discovered by multidisciplinary research team

November 20, 2017
A joint effort by breast cancer researchers and bioinformaticians has provided new insights into the molecular changes that drive breast development.

Brain cell advance brings hope for Creutzfeldt-Jakob disease

November 20, 2017
Scientists have developed a new system to study Creutzfeldt-Jakob disease in the laboratory, paving the way for research to find treatments for the fatal brain disorder.

Hibernating ground squirrels provide clues to new stroke treatments

November 17, 2017
In the fight against brain damage caused by stroke, researchers have turned to an unlikely source of inspiration: hibernating ground squirrels.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.